2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone,
BHT-QM,
BHT-quinone methide,
2607-52-5,
2,6-Di-t-butyl-4-methylene-2,5-cyclohexadienone,
UNII-49860VI52B,
2,6-Di-tert-butyl-4-methylene-2,5-cyclohexadienone,
49860VI52B,
Bht-quinone methide,
Bht-QM,
2,6-di-t-Butyl-4-methylene-2,5-cyclohexadiene-1-one,
2,5-Cyclohexadien-1-one, 2,6-bis(1,1-dimethylethyl)-4-methylene-,
AC1L32NP,
Everolimus Related Compound 5,
AC1Q691U,
SCHEMBL1252912,
2,6-ditert-butyl-4-methylene-cyclohexa-2,5-dien-1-one,
CTK4F7027,
DTXSID70180707,
JJQCWPWUHZFKBN-UHFFFAOYSA-N,
2,6-Bis(1,1-dimethylethyl)-4-methylene-2,5-cyclohexadien-1-one,
ZINC5351649,
AKOS015841124,
SC-69326,
TX-011677,
2,5-Cyclohexadien-1-one,2,6-bis(1,1-dimethylethyl),
2,6-Di-tert-butyl-4-methylene-2,5-cyclohexadien-1-one,
2,6-di-tertbutyl-4-methylene-2,5-cyclohexadiene-1-one,
2,6-ditert-butyl-4-methylidenecyclohexa-2,5-dien-1-one,
2,5-Cyclohexadien-1-one,2,6-bis(1,1-dimethylethyl)-4-methylene-,
2,5-Ccyclohexadien-1-one, 2,6-bis(1,1-dimethylethyl)-4-methylene-,
AR-1D5101,
C15-H22-O,
CID107736,
C024709,
2,6-di-tert-butyl-4-methylenecyclohexa-2,5-dienone,
2693-61-0,